Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks 50 Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
MBRX
Stock Latest News
Ratings
Moleculin Biotech: Positive Clinical Trial Results and Strategic Developments Support Buy Rating
13h ago
MBRX
Premium
Company Announcements
Moleculin Biotech Hosts Key Opinion Leaders Event
16h ago
8K
MBRX
Premium
The Fly
Moleculin Biotech releases KOL webcast to discuss Phase 1B/2 annamycin data
19h ago
MBRX
Premium
Market News
Moleculin Biotech Stock (MBRX) Dives 10% on Clinical Trial Results
1d ago
MBRX
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
2d ago
KO
BTC
Premium
Company Announcements
Moleculin Biotech Reports Positive Annamycin Trial Results
2d ago
8K
MBRX
Premium
The Fly
Moleculin Biotech reports efficacy results from Phase 1B/2 trial of annamycin
2d ago
MBRX
Premium
The Fly
Moleculin Biotech files to sell 10.99M shares of common stock, warrants
3d ago
MBRX
Premium
Company Announcements
Moleculin Biotech Faces Nasdaq Non-Compliance Notice
13d ago
8K
MBRX
Premium
Company Announcements
Moleculin Biotech’s Earnings Call: Trials and Triumphs
21d ago
MBRX
Premium
Ratings
Moleculin Biotech’s Growth Potential Highlighted by Phase 3 MIRACLE Trial and Strategic Advancements
22d ago
MBRX
Premium
Company Announcements
Moleculin Biotech Reports Q1 2025 Financial Results
22d ago
MBRX
Premium
The Fly
Moleculin Biotech reports Q1 EPS (69c) vs ($2.02) last year
23d ago
MBRX
Premium
Company Announcements
Moleculin Biotech’s Annamycin Trial Approved by EMA
25d ago
8K
MBRX
Premium
The Fly
Moleculin Biotech receives EMA approval to expand Phase 3 MIRACLE trial
25d ago
MBRX
Premium
Company Announcements
Moleculin Biotech Cancels Special Stockholders Meeting
27d ago
8K
MBRX
Premium
Company Announcements
Moleculin Biotech to Announce Q1 2025 Financial Results
30d ago
8K
MBRX
Premium
Company Announcements
Moleculin Biotech’s Annamycin Receives WHO Name Approval
1M ago
8K
MBRX
Premium
The Fly
Moleculin Biotech announces WHO approval of ‘naxtarubicin’ international name
1M ago
MBRX
Premium
Pre-Earnings
MBRX Upcoming Earnings Report: What to Expect?
1M ago
MBRX
Premium
Company Announcements
Moleculin Biotech Secures Two New U.S. Patents
1M ago
8K
MBRX
Premium
The Fly
Moleculin Biotech announces granting of two new U.S. patents
1M ago
MBRX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.